Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis

Annals of Hematology

Volumn 91, Issue 3, 2012, Pages 399-406

  Caccialanza, Riccardo ^a   Palladini, Giovanni ^b   Klersy, Catherine ^a,b   Cereda, Emanuele ^a   Bonardi, Chiara ^a   Cameletti, Barbara ^a   Montagna, Elisabetta ^a   Russo, Paola ^b   Foli, Andrea ^b   Milani, Paolo ^b   Lavatelli, Francesca ^b   Merlini, Giampaolo ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Amyloidosis; Malnutrition; Nutritional status; Prealbumin; Quality of life

Indexed keywords

C REACTIVE PROTEIN; CREATININE; IMMUNOGLOBULIN LIGHT CHAIN; PREALBUMIN;

ADULT; AGE; AGED; AMYLOIDOSIS; ARM CIRCUMFERENCE; ARM MUSCLE; ARTICLE; BODILY PAIN; BODY MASS; CALORIC INTAKE; CLINICAL ASSESSMENT; COMORBIDITY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS; EMOTIONAL PROBLEM; EMOTIONALITY; FEMALE; FOOD INTAKE; FUNCTIONAL STATUS; GENDER; HEALTH STATUS; HUMAN; IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MENTAL HEALTH; MID ARM MUSCLE CIRCUMFERENCE; NUTRITIONAL STATUS; OUTPATIENT; PAIN; PHASE 1 CLINICAL TRIAL; PHYSICAL FUNCTIONING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; QUALITY OF LIFE; SHORT FORM 36; SOCIAL INTERACTION; STAGING; VITALITY; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; ANTHROPOMETRY; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIET; ENERGY INTAKE; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84857356065     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1309-x     Document Type: Article

References (41)

1. G Merlini MJ Stone 2006 Dangerous small B-cell clones Blood 108 2520 2530 16794250 10.1182/blood-2006-03-001164 1:CAS:528:DC%2BD28XhtFWgt7fJ
2. A Dispenzieri M Gertz R Kyle, et al. 2004 Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis J Clin Oncol 22 3751 3757 15365071 10.1200/JCO.2004.03.029 1:CAS:528:DC%2BD2cXhtVCitb7K (Pubitemid 41095215)
3. G Palladini A Barassi C Klersy, et al. 2010 The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis Blood 116 3426 3430 20644111 10.1182/blood-2010-05-286567 1:CAS:528:DC%2BC3cXhsVKksLfI
4. R Caccialanza G Palladini C Klersy, et al. 2006 Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis (AL) Am J Clin Nutr 83 350 354 16469994 1:CAS:528:DC%2BD28Xhs1ehsbw%3D (Pubitemid 44713197)
5. P Ravasco I Monteiro-Grillo PM Vidal ME Camilo 2004 Cancer: disease and nutrition are key determinants of patients' quality of life Support Care Cancer 12 246 252 14997369 10.1007/s00520-003-0568-z (Pubitemid 38660747)
6. MM Marín Caro A Laviano C Pichard 2007 Impact of nutrition on quality of life during cancer Curr Opin Clin Nutr Metab Care 10 480 487 17563467 10.1097/MCO.0b013e3281e2c983 (Pubitemid 46934118)
7. DC Seldin JJ Anderson V Sanchorawala, et al. 2004 Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation Blood 104 1888 1893 15155460 10.1182/blood-2004-01-0089 1:CAS:528:DC%2BD2cXns1Oku7w%3D (Pubitemid 39202302)
8. European Medicines Agency (2005) Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. Doc. ref. EMEA/CHMP/EWP/139391/2004. London (UK)
9. U.S. Department of Health and Human Services, Food and Drug Administration (2006) Patient-reported outcome measures: use in medical product development to support labeling claims. February
10. E Arbustini L Verga M Concardi, et al. 2002 Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis Amyloid 9 108 114 12440483 1:CAS:528: DC%2BD38Xmt1Wlurk%3D (Pubitemid 34787804)
11. M Gertz R Comenzo R Falk, et al. 2004 Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004 Am J Hematol 79 319 328 10.1002/ajh.20381 (Pubitemid 41098849)
12. MM Oken RH Creech DC Tormey, et al. 1982 Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 649 655 7165009 10.1097/00000421-198212000-00014 1:STN:280:DyaL3s7kvFOgsw%3D%3D (Pubitemid 13149996)
13. Quetelet A (1835) Sur l'Homme et le Developpement de ses Facultes, ou Essai des Physique Sociale (On Man and the Development of his Faculties, or Treatise on Social Physics). Bachelier, Paris
14. AR Frisancho 1981 New norms of upper limb fat and muscle areas for assessment of nutritional status Am J Clin Nutr 34 2540 2545 6975564 1:STN:280:DyaL38%2FmsFegsQ%3D%3D (Pubitemid 12176089)
15. WHO Expert Committee (1995) The use and interpretation of anthropometry. WHO Technical Report Series n. 854. WHO, Geneva
16. KC Fearon AC Voss DS Hustead Cancer Cachexia Study Group 2006 Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis Am J Clin Nutr 83 1345 1350 16762946 1:CAS:528:DC%2BD28XlvFCmtbg%3D (Pubitemid 44713065)
17. CA McHorney JE Ware Jr JF Lu CD Sherbourne 1994 The MOS 36-item Short-Form Health Survey (SF-36), III: tests of data quality, scaling assumptions, and reliability across diverse patient groups Med Care 32 40 66 8277801 10.1097/00005650-199401000-00004 1:STN:280:DyaK2c7gsVeltQ%3D%3D
18. JE Ware Jr CD Sherbourne 1992 The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection Med Care 30 473 483 1593914 10.1097/00005650-199206000-00002
19. CA McHorney JE Ware Jr AE Raczek 1993 The MOS 36-Item Short-Form Health Survey (SF-36), II: psychometric and clinical tests of validity in measuring physical and mental health constructs Med Care 31 247 263 8450681 10.1097/00005650-199303000-00006 1:STN:280:DyaK3s7ps1antA%3D%3D
20. JE Ware Jr M Kosinski MS Bayliss, et al. 1995 Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study Med Care 33 AS264 AS279 7723455 10.1097/00005650-199501001-00005
21. Ware JE Jr, Kosinski M (2001) SF-36 physical and mental health summary scales: a manual for users of version 1, 2nd edn. QualityMetric Inc., Lincoln
22. Ware JE Jr, Kosinski M, Gandek B (2000) SF-36 health survey: manual and interpretation guide. QualityMetric Inc., Lincoln
23. Istituto Scotti Bassani (1989) Atlante Ragionato di Alimentazione. Istituto Scotti Bassani per la ricerca e l'informazione scientifica e nutrizionale, Milano
24. Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione (I.N.R.A.N.) (2000) Tabelle di Composizione degli Alimenti. Aggiornamento 2000. EDRA Medical Publishing and New Media
25. DC Frankenfield ER Muth WA Rowe 1998 The Harris-Benedict studies of human basal metabolism: history and limitations J Am Diet Assoc 98 439 445 9550168 10.1016/S0002-8223(98)00100-X 1:STN:280:DyaK1c3gvFGisQ%3D%3D (Pubitemid 28165024)
26. STATA Corporation (2010) STATA statistical software: release 11.1. College Station
27. A Coates V Gebski JF Bishop, et al. 1987 Improving the quality of life during chemotherapy for advanced breast cancer: a comparison of intermittent and continuous treatment strategies N Engl J Med 317 1490 1495 3683485 10.1056/NEJM198712103172402 1:STN:280:DyaL1c%2FmsFOntg%3D%3D (Pubitemid 17160543)
28. JF Bishop J Dewar GC Toner, et al. 1999 Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer J Clin Oncol 17 2355 2364 10561297 1:CAS:528:DyaK1MXltlylt7o%3D (Pubitemid 29368233)
29. AD Seidman CA Hudis L Norton 1995 Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer: from advanced disease to adjuvant therapy Semin Oncol 22 S8 3 8 7543701 1:CAS:528: DyaK2MXosVaqs74%3D
30. P Ravasco I Monteiro Grillo M Camilo 2007 Cancer wasting and quality of life react to early individualized nutritional counselling! Clin Nutr 26 7 15 17166637 10.1016/j.clnu.2006.10.005 (Pubitemid 46179128)
31. Y Ingenbleek V Young 1994 Transthyretin (prealbumin) in health and disease: nutritional implications Annu Rev Nutr 14 495 533 7946531 10.1146/annurev.nu.14.070194.002431 1:CAS:528:DyaK2cXmtVeqsLY%3D (Pubitemid 24261848)
32. N Vasiljevic S Sonja Ralevic J Marinkovic, et al. 2008 The assessment of health-related quality of life in relation to the body mass index value in the urban population of Belgrade Health Qual Life Outcomes 6 106 19040759 10.1186/1477-7525-6-106
33. N Guler F Kuzu 2009 The health-related quality of life of the health professionals working in the primary healthcare centers and its correlation with selected sociodemographic factors in Sivas, a central Anatolian city Scientific Research and Essay 4 1547 1552
34. M Muscaritoli SD Anker J Argilés, et al. 2010 Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics" Clin Nutr 29 154 159 20060626 10.1016/j.clnu.2009.12.004 1:STN:280:DC%2BC3c3isFOltA%3D%3D
35. F Bozzetti L Mariani 2009 Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group JPEN 33 361 367 10.1177/0148607108325076
36. SW Dubrey K Cha J Anderson, et al. 1998 The clinical features of immunoglobulin light-chain amyloidosis (AL) with heart involvement Q J Med 91 141 157 10.1093/qjmed/91.2.141 1:STN:280:DyaK1c3ktVSntg%3D%3D (Pubitemid 28102667)
37. IH Rutishauser 2005 Dietary intake measurements Public Health Nutr 8 1100 1107 16277822 10.1079/PHN2005798 (Pubitemid 43266300)
38. E Cereda A Vanotti 2008 Short dietary assessment improves muscle dysfunction identification by Geriatric Nutritional Risk Index in uncomplicated institutionalised patients over 70 years old Clin Nutr 27 126 132 17976875 10.1016/j.clnu.2007.09.006 (Pubitemid 351201854)
39. PO Iversen F Wisløff N Gulbrandsen 2010 Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support Clin Nutr 29 488 491 20044183 10.1016/j.clnu.2009.12.002 1:CAS:528:DC%2BC3cXpsFOqsb8%3D
40. J Arends G Bodoky F Bozzetti, et al. 2006 ESPEN Guidelines on enteral nutrition: non-surgical oncology Clin Nutr 25 245 259 16697500 10.1016/j.clnu.2006.01.020 1:STN:280:DC%2BD28zktVGltQ%3D%3D (Pubitemid 43811685)
41. F Bozzetti J Arends K Lundholm, et al. 2009 ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology Clin Nutr 28 445 454 19477052 10.1016/j.clnu.2009.04.011 1:STN:280:DC%2BD1Mris1egtg%3D%3D